证券代码：300562 证券简称：乐心医疗 公告编号：2025-125 广东乐心医疗电子股份有限公司 关于"增益1号"员工持股计划实施进展的公告 乐心医疗 2025 年公告 公司于 2025 年 11 月 26 日在中国证券登记结算有限责任公司完成了本员工 持股计划专用证券账户开立工作，账户名称为：广东乐心医疗电子股份有限公司 —"增益 1 号"员工持股计划，证券账户号码为：0899*****3。 公司将持续关注"增益 1 号"员工持股计划的实施进展，并按照法律法规的 要求及时履行信息披露义务，敬请广大投资者注意投资风险。 特此公告。 广东乐心医疗电子股份有限公司 董事会 二〇二五年十一月二十七日 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 广东乐心医疗电子股份有限公司（以下简称"公司"）分别于 2025 年 9 月 9 日、2025 年 9 月 29 日召开第五届董事会第五次会议与 2025 年第三次临时股东 会审议通过了《关于<"增益 1 号"员工持股计划（草案）>及其摘要的议案》 等议案，同意公司通过二级市场购入标的股票的方式实施"增益 1 号"员工 ...

Core Insights - The ChiNext Medical Index (970082) closed at 3661.9 points on November 27, with a slight increase of 0.18% and a trading volume of 8.516 billion yuan, reflecting a turnover rate of 1.15% [1] - Among the index constituents, 27 stocks rose while 22 fell, with Lexin Medical leading the gainers at 2.04% and Dean Diagnostics leading the decliners at 2.96% [1] Index Constituents Summary - The top ten constituents of the ChiNext Medical Index include: - Yuaner Eye Hospital (sz300015) with a weight of 8.87% and a latest price of 11.40, down by 0.26% [1] - Mindray Medical (sz300760) with a weight of 8.02% and a latest price of 196.30, up by 1.50% [1] - Kanglong Chemical (sz300759) with a weight of 7.41% and a latest price of 28.87, down by 0.07% [1] - Tigermed (sz300347) with a weight of 7.40% and a latest price of 51.20, up by 0.23% [1] - Lepu Medical (sz300003) with a weight of 5.65% and a latest price of 15.87, up by 0.13% [1] - New Industry (sz300832) with a weight of 5.17% and a latest price of 58.28, down by 0.99% [1] - Aimeike (sz300896) with a weight of 5.15% and a latest price of 146.26, up by 0.83% [1] - Yingke Medical (sz300677) with a weight of 4.24% and a latest price of 41.53, up by 1.94% [1] - Furuijia (sz300049) with a weight of 4.18% and a latest price of 67.08, up by 1.36% [1] - BGI Genomics (sz300676) with a weight of 3.07% and a latest price of 46.37, down by 0.39% [1] Capital Flow Analysis - On the same day, the ChiNext Medical Index constituents experienced a net outflow of 114 million yuan from institutional investors and 105 million yuan from retail investors, while retail investors saw a net inflow of 220 million yuan [1] - Detailed capital flow for selected stocks includes: - Aimeike (sz300896) with a net inflow of 46.9918 million yuan from institutional investors [2] - Lexin Medical (sz300562) with a net inflow of 41.5425 million yuan from institutional investors [2] - Mindray Medical (sz300760) with a net inflow of 33.0761 million yuan from institutional investors [2] - Furuijia (sz300049) with a net inflow of 13.6788 million yuan from institutional investors [2]

Group 1 - The A-share market saw a rise in some elder care-related stocks, with Yueshin Health hitting the daily limit up, followed by companies like Ousheng Electric, Yahua Electronics, Aojiahua, Xinlong Health, and Kelaibao also experiencing gains [1] - The State Council held a press conference to introduce policies aimed at enhancing the adaptability of consumer goods supply and demand to further promote consumption [1] - The Ministry of Industry and Information Technology announced plans to collaborate with relevant departments to strengthen the research and development of products such as elder care service robots, age-friendly clothing, and easy-to-swallow foods [1] Group 2 - Yueshin Health (002162) experienced a price increase of 9.94%, with a total market value of 4.884 billion and a year-to-date increase of 53.47% [2] - Other notable stocks include Haixia Innovation (300300) with a 5.31% increase and a market value of 9.129 billion, and ST Xinhua Jin (600735) with a 5.03% increase and a market value of 2.688 billion [2] - The MACD golden cross signal has formed, indicating a positive trend for these stocks [2]

Core Viewpoint - Le Xin Medical has received approval for the renewal of its medical device registration certificate from the Guangdong Provincial Drug Administration [1] Group 1 - The announcement was made on the evening of November 26 [1] - The approval pertains to the application submitted by Shenzhen Ruikang Hongye Technology Development Co., Ltd., a subsidiary of Le Xin Medical [1] - This approval is significant for the company's operations in the medical device sector [1]

Core Viewpoint - Leasen Medical (300562.SZ) announced that its subsidiary, Shenzhen Ruikang Hongye Technology Development Co., Ltd., has received approval from the Guangdong Provincial Drug Administration for the renewal of its medical device registration for the ECG information network management system software [1] Group 1 - The approval pertains to the renewal of the medical device registration certificate [1] - The product involved is the ECG information network management system software [1]

Core Viewpoint - The announcement indicates that the medical device registration extension for the ECG information network management system software has been approved, extending its validity until May 26, 2031 [1] Group 1 - The ECG information network management system software was originally set to expire on May 26, 2026, and has now been extended for an additional five years [1] - The software consists of a system installation CD and random system files, designed for receiving, viewing, editing static and dynamic ECG data, printing reports, and statistical data functions, but does not include automatic diagnosis features [1]

乐心医疗 2025 年公告 证券代码：300562 证券简称：乐心医疗 公告编号：2025-124 关于控股子公司完成医疗器械注册证延续注册的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 广东乐心医疗电子股份有限公司（以下简称"公司"）控股子公司深圳市瑞 康宏业科技开发有限公司（以下简称"瑞康宏业"）近日接到广东省药品监督管 理局的通知，获悉其申报的医疗器械注册证延续注册事项已通过审批，现将相关 情况公告如下： 1、本次延续的基本情况 | 产品名称 | 申请事项 | 注册证编号 | 分类 | 规格型号 | | | 延续情况 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 心电信息网络 | 第二类医疗器 | 粤械注准 | 类 II | might-net | 年 2026 | 月 05 | 该产品医疗器械注册证将于 26 | 日到期，本次延 | | 管理系统软件 | 械注册证延续 | 20162210983 | | | | | | | | | | | | | 续至 | 2031 ...

Market Overview - The medical device sector experienced a decline of 0.38% on November 26, with Kangwei Century leading the drop [1] - The Shanghai Composite Index closed at 3864.18, down 0.15%, while the Shenzhen Component Index closed at 12907.83, up 1.02% [1] Top Performers - Haobor (688656) saw a significant increase of 9.38%, closing at 201.80 with a trading volume of 17,200 lots [1] - Shuoshi Biology (6668889) rose by 4.04%, closing at 69.82 with a trading volume of 21,500 lots [1] - Lexin Medical (300562) increased by 3.88%, closing at 14.20 with a trading volume of 107,400 lots [1] Underperformers - Kangwei Century (688426) fell by 10.78%, closing at 27.80 with a trading volume of 33,000 lots [2] - Boxin Biology (920504) decreased by 5.98%, closing at 22.97 with a trading volume of 8,514 lots [2] - Zhengchuan Co. (603976) dropped by 5.25%, closing at 21.30 with a trading volume of 33,800 lots [2] Capital Flow - The medical device sector saw a net outflow of 371 million yuan from institutional investors, while retail investors contributed a net inflow of 43.54 million yuan [2][3] - The top net inflows from institutional investors were seen in Lexin Medical (300562) with a net outflow of 33.13 million yuan [3] - The highest net inflow from retail investors was in Yuyue Medical (002223) with a net inflow of 24.16 million yuan [3]

广东乐心医疗电子股份有限公司 关于"增益1号"员工持股计划实施进展的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 乐心医疗 2025 年公告 证券代码：300562 证券简称：乐心医疗 公告编号：2025-123 截至本公告披露日，本员工持股计划已召开第一次持有人会议设立管理委员 会并选举管理委员会委员。目前员工已完成认购款缴纳，公司正在积极推进证券 账户开立等工作，尚未开始从二级市场购入本公司股票。 公司将持续关注"增益 1 号"员工持股计划的实施进展，并按照法律法规的 要求及时履行信息披露义务，敬请广大投资者注意投资风险。 特此公告。 广东乐心医疗电子股份有限公司 董事会 二〇二五年十一月二十五日 广东乐心医疗电子股份有限公司（以下简称"公司"）分别于 2025 年 9 月 9 日、2025 年 9 月 29 日召开第五届董事会第五次会议与 2025 年第三次临时股东 会审议通过了《关于<"增益 1 号"员工持股计划（草案）>及其摘要的议案》 等议案，同意公司通过二级市场购入标的股票的方式实施"增益 1 号"员工持股 计划（以下简称"本员工持股计划 ...

广东乐心医疗电子股份有限公司（以下简称"公司"）2024 年员工持股计 划（以下简称"本员工持股计划"）第二次持有人会议于 2025 年 11 月 19 日以 通讯方式召开。本次会议由本员工持股计划管理委员会委员刘猛召集并主持，应 参会 17 人，实际参会 17 人，代表公司本员工持股计划份额 332.25 万份，占公 司本员工持股计划目前总份额的 100%。 会议的召集、召开程序符合《中华人民共和国公司法》等相关法律法规以及 公司 2024 年员工持股计划等相关规定。 2024 年员工持股计划第二次持有人会议决议公告 二、会议审议情况 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、会议召开情况 乐心医疗 2025 年公告 证券代码：300562 证券简称：乐心医疗 公告编号：2025-120 广东乐心医疗电子股份有限公司 公司 2024 年员工持股计划（以下简称"本员工持股计划"）管理委员会委 员黄林香女士因离职不再符合本员工持股计划参与资格，不再担任本员工持股计 划管理委员会委员。为完善公司本员工持股计划管理委员会架构，根据《广东乐 心医疗电子股份有 ...